Stay updated on Pembrolizumab in Esophageal Ca Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Esophageal Ca Clinical Trial page.

Latest updates to the Pembrolizumab in Esophageal Ca Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe history section gained new content areas (IPDSharing, Study Design, Study Status, and Study Identification) on 2026-05-13, accompanied by a new revision entry (Revision: v3.5.4). This updates how the study record is structured and tracked over time.SummaryDifference0.2%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page’s interface revision label was updated from v3.5.2 to v3.5.3, reflecting a site/platform version change without altering the underlying study history details.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check81 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the page history.SummaryDifference0.0%

- Check109 days agoChange DetectedRevision: v3.4.2 was added to the page history. The previous notice about government funding lapse and operating status was removed.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in Esophageal Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Esophageal Ca Clinical Trial page.